Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

As one of Ireland's port villages, Cobh in Co Cork has a rich history. If you claim Irish descent, then there is a good chance that your ancestors left Ireland through Cobh (pronounced Cove ...

The alarm was raised at around 6.30pm and four units of Cork City Fire Brigade rushed to the scene at the Sarsfield Court Industrial Estate in Glanmire An investigation is underway after several ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $91.41, reflecting a -0.51% shift from the previouse trading day's closing. The stock's performance was behind the S&P ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other dividend stocks. Macroeconomic factors have weighed on US stocks in the final ...

It's the only budget supermarket right in the heart of Cork City - a place for those without a car or who live in and around the city centre can go to do their Big Shop, snag a cheap lunch or just ...

HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer. According to GlobalData, Phase II drugs for Human Papillomavirus ...

Gilead's stock is rated a "buy" due to its thriving HIV business, promising oncology pipeline, and potential for long-term growth despite some volatility. The company's Q3 earnings show strong ...

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.